EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	73.39M -17.2%
Revenue (ttm)	66.87M +0.6%
Net Income	6.73M -3.4%
EPS	0.15 -10.0%
Shares Out	47.04M
PE Ratio	10.72
Forward PE	n/a
Dividend	0.04 (2.45%)
Ex-Dividend Date	Nov 24, 2025

Volume	29,723
Average Volume	19,635
Open	1.630
Previous Close	1.635
Day's Range	1.560 - 1.660
52-Week Range	1.290 - 3.380
Beta	0.56
RSI	45.77
Earnings Date	Feb 26, 2026

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. Th...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In fiscal year 2025, EZZ Life Science Holdings's revenue was 66.87 million, an increase of 0.65% compared to the previous year's 66.44 million. Earnings were 6.73 million, a decrease of -3.36%.